Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial
- 1Cardiovascular Division, University of Texas Health Science Center, 6431 Fannin, MSB 1.246, Houston, TX 77030, USA. david.aguilar@uth.tmc.edu
- 0Cardiovascular Division, University of Texas Health Science Center, 6431 Fannin, MSB 1.246, Houston, TX 77030, USA. david.aguilar@uth.tmc.edu
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Newly diagnosed diabetes after myocardial infarction (MI) carries the same poor prognosis as pre-existing diabetes. This highlights the significant impact of metabolic abnormalities on adverse cardiovascular outcomes in MI patients.
Area Of Science
- Cardiology
- Endocrinology
- Clinical Research
Background
- Prior diabetes diagnosis is linked to worse outcomes post-myocardial infarction (MI).
- The specific risk associated with new-onset diabetes following MI remains unclear.
Purpose Of The Study
- To evaluate the risk of mortality and major cardiovascular events in patients with newly diagnosed diabetes versus previously known diabetes after acute MI.
Main Methods
- Analysis of 14,703 patients from the VALIANT trial, categorized by diabetic status: previously known, newly diagnosed, or no diabetes.
- Comparison of adjusted risks for death and cardiovascular events at 1 year post-enrollment.
Main Results
- Newly diagnosed diabetes (4%) and previously known diabetes (23%) showed similarly increased adjusted risks of 1-year mortality (HR 1.50 and 1.43, respectively) and cardiovascular events (HR 1.34 and 1.37, respectively).
- Patients with newly diagnosed diabetes were younger and had fewer comorbidities at baseline compared to those with previously known diabetes.
Conclusions
- Both newly diagnosed and previously known diabetes mellitus are associated with adverse long-term outcomes after acute MI.
- The similar poor prognosis in newly diagnosed diabetes patients, despite favorable baseline characteristics, suggests a significant role of metabolic abnormalities in adverse outcomes.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.